Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR T-cell Therapy”

1,419 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,419 results

Not applicableWithdrawnNCT06508346
What this trial is testing

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV

Who this might be right for
ANCA Associated VasculitisCAR-T Cell Therapy
The Children's Hospital of Zhejiang University School of Medicine
Testing effectiveness (Phase 2)UnknownNCT03896854
What this trial is testing

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 15
Early research (Phase 1)Not Yet RecruitingNCT06647329
What this trial is testing

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

Who this might be right for
CAR-T Cell TherapyLymphomas
Mingzhi Zhang 30
Early research (Phase 1)Active Not RecruitingNCT05784441
What this trial is testing

JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

Who this might be right for
Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLC 21
Very early researchNot Yet RecruitingNCT07266337
What this trial is testing

CD19/BCMA CAR-T for SLE

Who this might be right for
SLE - Systemic Lupus Erythematosus
Chengdu Ucello Biotechnology Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07066995
What this trial is testing

Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic CarcinomaPancreatic Cancer Non-resectable+1 more
Essen Biotech 60
Very early researchNot Yet RecruitingNCT06886919
What this trial is testing

Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus

Who this might be right for
Difficult to Treat Systemic Lupus Erythematosus
Beijing Immunochina Medical Science & Technology Co., Ltd. 6
Early research (Phase 1)Active Not RecruitingNCT03617198
What this trial is testing

CD4 CAR+ ZFN-modified T Cells in HIV Therapy

Who this might be right for
Hiv
University of Pennsylvania 12
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Early research (Phase 1)Looking for participantsNCT03240328
What this trial is testing

The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

Who this might be right for
HIV/AIDS
Guangzhou 8th People's Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07569965
What this trial is testing

Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCL

Who this might be right for
Mantle Cell Lymphoma (MCL)
Miltenyi Biomedicine GmbH 52
Very early researchUnknownNCT05085444
What this trial is testing

CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma

Who this might be right for
SclerodermaAutoimmune Diseases
Zhejiang University 9
Testing effectiveness (Phase 2)Looking for participantsNCT07178431
What this trial is testing

MB-CART2019.1 in Refractory Multiple Sclerosis

Who this might be right for
Multiple SclerosisCAR T Cell Therapy
Miltenyi Biomedicine GmbH 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07771361
What this trial is testing

BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma

Who this might be right for
Non-Hodgkin Lymphoma Refractory/ RelapsedMultiple Myeloma RefractoryMultiple Myeloma in Relapse+5 more
Luminary Therapeutics 90
Testing effectiveness (Phase 2)Looking for participantsNCT06514794
What this trial is testing

WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Allotera Therapeutics 125
Early research (Phase 1)Not Yet RecruitingNCT07676266
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more
The Affiliated Hospital of Qingdao University 18
Not applicableUnknownNCT06142175
What this trial is testing

Relmacabtagene Autoleucel in Patients With LBCL

Who this might be right for
Large B-cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd. 200
Very early researchStudy completedNCT05902845
What this trial is testing

RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL

Who this might be right for
NeoplasmsHematologic NeoplasmsHematologic Diseases
Xiaoyu Zhu 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT06552572
What this trial is testing

Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Samsung Medical Center 30
Large-scale testing (Phase 3)Looking for participantsNCT06328777
What this trial is testing

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Diseases
Cabaletta Bio 37
Next Page